Filtered By:
Source: Atherosclerosis
Condition: Patent Foramen Ovale

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 17 results found since Jan 2013.

Causes of ischemic stroke in young adults versus non-young adults: A multicenter hospital-based observational study
CONCLUSIONS: Certain embolic sources and uncommon causes may be etiologically important causes of ischemic stroke in young adults. However, the contribution of conventional vascular risk factors and lifestyle-related risk factors is not negligible with advancing age, even in young adults.PMID:35830430 | DOI:10.1371/journal.pone.0268481
Source: Atherosclerosis - July 13, 2022 Category: Cardiology Authors: Yuichiro Ohya Ryu Matsuo Noriko Sato Fumi Irie Kuniyuki Nakamura Yoshinobu Wakisaka Tetsuro Ago Masahiro Kamouchi Takanari Kitazono Investigators for Fukuoka Stroke Registry Source Type: research

ADAMTS-13 activity in stroke of known and unknown cause: Relation to vascular risk factor burden
CONCLUSION: ADAMTS-13 activity is inversely correlated with the number of vascular risk factors across different stroke etiologies. Further study is warranted to establish ADAMTS-13 as a mediator of cerebrovascular risk.PMID:36703637 | PMC:PMC9871749 | DOI:10.3389/fneur.2022.1045478
Source: Atherosclerosis - January 27, 2023 Category: Cardiology Authors: Gerrit M Grosse Andrei Leotescu Jan-Thorben Sieweke Sonja Schneppenheim Ulrich Budde Nora L Ziegler Saskia Biber Maria M Gabriel Johanna Ernst Ramona Schuppner Ralf Lichtinghagen Udo Bavendiek Julian Widder Karin Weissenborn Source Type: research

Long-term risk of recurrent cerebrovascular events after patent foramen ovale closure: Results from a real-world stroke cohort
CONCLUSION: In this long-term follow-up-study of patients with a cerebral ischaemic event who had received PFO-closure with different devices, rates of recurrent stroke/TIA were low and largely related to large artery atherosclerosis and small vessel disease. Thorough vascular risk factor control seems crucial for secondary stroke prevention in patients treated for PFO-related stroke.PMID:37658692 | DOI:10.1177/23969873231197564
Source: Atherosclerosis - September 2, 2023 Category: Cardiology Authors: Markus Kneihsl Susanna Horner Isra Hatab Nora Sch öngrundner Diether Kramer Gabor Toth-Gayor Gernot Grangl Gerit W ünsch Simon Fandler-H öfler Melanie Haidegger Natalie Berger Sai Veeranki Urs Fischer Christian Enzinger Thomas Gattringer Source Type: research

Ischemic stroke in young patients in Medell ín, Colombia
CONCLUSIONS: The high frequency of traditional risk factors in young patients highlights the need to optimize primary and secondary prevention plans. This study provides new insights about the relevance of illicit substance abuse in Colombia as a cause of stroke in young patients, unlike the previous one conducted in Bogotá. Infectious causes were other peculiarities found. It is necessary to investigate the reasons for the high proportion of undetermined causes.PMID:36138366 | DOI:10.1186/s12883-022-02895-9
Source: Atherosclerosis - September 22, 2022 Category: Cardiology Authors: Juan Diego Vargas-Murcia Sandra Patricia Isaza-Jaramillo Dionis Magnary Vallejo-Mesa Daniela Carvajal-Mu ñoz Source Type: research

Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines
CONCLUSIONS: An individual approach and targeted diagnostics using advanced medical technologies in selected patients, who may benefit from a tailored treatment regimen, can help reveal a probable cause in the majority of strokes and TIAs previously classified as cryptogenic.PMID:35146751 | DOI:10.1111/ane.13590
Source: Atherosclerosis - February 11, 2022 Category: Cardiology Authors: Barbara Ratajczak-Tretel Anna Tancin Lambert Dan Atar Anne Hege Aamodt Source Type: research

Cryptogenic Ischemic Stroke in Migraine: Role of Patent Foramen Ovale
CONCLUSION: In a young adult population with CIS, MWA was strongly associated with possibly causal PFO, i.e., with a large shunt or combined with an interatrial septal aneurysm.PMID:35295806 | PMC:PMC8915651 | DOI:10.3389/fpain.2022.823595
Source: Atherosclerosis - March 17, 2022 Category: Cardiology Authors: C édric Gollion Fleur Lerebours Marianne Barbieux-Guillot Vincent Fabry Vincent Larrue Source Type: research

Bubble Test and Carotid Ultrasound to Guide Indication of Transesophageal Echocardiography in Young Patients With Stroke
CONCLUSIONS: Bubble test and carotid ultrasound could be used for the individual decision for/against TEE in patients with cryptogenic stroke ≤60 years. If they are unremarkable, TEE can be omitted with high safety regarding secondary prevention. If bubble test is positive and/or carotid ultrasound shows atherosclerosis, TEE should be carried out if PFO or aortic atheroma are potentially relevant for further patient management.PMID:35309558 | PMC:PMC8931264 | DOI:10.3389/fneur.2022.836609
Source: Atherosclerosis - March 21, 2022 Category: Cardiology Authors: Ernst Mayerhofer Dirk Kanz Brigitte Guschlbauer Christopher D Anderson Alexander Asmussen Sebastian Grundmann Christoph Strecker Andreas Harloff Source Type: research

Unique Clinicopathologic Subclassifiers of Cryptogenic Cerebral Emboli
CONCLUSIONS: Certain clinical and radiographic features may be useful in predicting the proximal source of occult cerebral emboli, and can be used for cost-effective outpatient diagnostic testing.PMID:35279004 | DOI:10.1016/j.jstrokecerebrovasdis.2022.106427
Source: Atherosclerosis - March 12, 2022 Category: Cardiology Authors: James E Siegler Lauren Thau Taryn Hester Terri Yeager Nicholas Vigilante Scott Kamen Mark Heslin Ryan Shannon Linda Zhang Miriam Butler Christopher Higham Solomon Oak Jared Wolfe Parth Patel Pratit Patel Jesse M Thon Source Type: research

Unexplained arterial thrombosis: approach to diagnosis and treatment
We present a structured approach to diagnosis with consideration of common causes, including atherosclerosis and embolism, as well as uncommon causes, including medications and substances, vascular and anatomic abnormalities, systemic disorders, and thrombophilias. We highlight areas of management that have evolved within the past 5 years, including the use of dual-pathway inhibition in atherosclerotic disease, antithrombotic therapy selection in embolic stroke of undetermined source and left ventricular thrombus, the role of closure of patent foramen ovale for secondary stroke prevention, and the thrombotic potential of c...
Source: Atherosclerosis - December 10, 2021 Category: Cardiology Authors: Jori E May Stephan Moll Source Type: research